Zobrazeno 1 - 10 of 83 pro vyhledávání: '"Anthony C, Wong"'
1
Akademický článek
Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer
Autor: Nancy Y. Greenland, Matthew R. Cooperberg, Anthony C. Wong, Emily Chan, Peter R. Carroll, Jeffry P. Simko, Bradley A. Stohr
Publikováno v: Investigative and Clinical Urology, Vol 63, Iss 1, Pp 27-33 (2022)
Purpose: Among Gleason pattern 4 types, cribriform pattern is associated with the worst outcomes. We hypothesized that larger cribriform patterns would be associated with increased Decipher scores and higher biochemical recurrence (BCR) risk in Gleas
Externí odkaz: https://doaj.org/article/4519149b2a244a2c94fcee728d76039a
Zobrazit plný text záznamu
2
Akademický článek
Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost
Autor: Christina Phuong, Jason W. Chan, Lisa Ni, Phillip Wall, Osama Mohamad, Anthony C. Wong, I.-Chow Hsu, Albert J. Chang
Publikováno v: Radiation Oncology, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background To evaluate acute and late genitourinary and gastrointestinal toxicities and patient reported urinary and sexual function following accelerated, hypofractionated external beam radiotherapy to the prostate, seminal vesicles and pel
Externí odkaz: https://doaj.org/article/5a9deeb61a3244b2831c7c2d854ae681
Zobrazit plný text záznamu
3
Akademický článek
Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial
Autor: Kevin Shee, MD, PhD, Claire M. de la Calle, MD, Albert J. Chang, MD, PhD, Anthony C. Wong, MD, PhD, Felix Y. Feng, MD, Alexander R. Gottschalk, MD, PhD, Peter R. Carroll, MD, MPH, Hao G. Nguyen, MD, PhD
Publikováno v: Advances in Radiation Oncology, Vol 7, Iss 5, Pp 100941- (2022)
Background: Enzalutamide is an antiandrogen used to treat both metastatic and nonmetastatic prostate cancer. Here we present results from a phase 2 trial designed to determine the safety, tolerability, and efficacy of adding enzalutamide to standard
Externí odkaz: https://doaj.org/article/ed25005708004bb9a4745b9b93ffa0b3
Zobrazit plný text záznamu
5
Akademický článek
TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
Autor: Li Zhang, Divya Natesan, Lawrence Fong, Emily Chan, David Y Oh, Son Ho, Ivan de Kouchkovsky, Errol J Philip, Francis Wright, Daniel M Kim, Daniel Kwon, Hansen Ho, Sima P Porten, Anthony C Wong, Arpita Desai, Franklin W Huang, Jonathan Chou, Raj S Pruthi, Eric J Small, Terence W Friedlander, Vadim S Koshkin
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Immune checkpoint inhibitors (ICI) can achieve durable responses in a subset of patients with locally advanced or metastatic urothelial carcinoma (aUC). The use of tumor genomic profiling in clinical practice may help suggest biomarkers to
Externí odkaz: https://doaj.org/article/daffc1a2d771420089913bf03e6aaad2
Zobrazit plný text záznamu
6
Akademický článek
Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines
Autor: Adil S. Akthar, MD, Anthony C. Wong, MD, PhD, Akash D. Parekh, MD, Greg Hubert, BS, RT(T), CMD, Christina H. Son, MD, Charles A. Pelizzari, PhD, Stanley L. Liauw, MD
Publikováno v: Advances in Radiation Oncology, Vol 3, Iss 3, Pp 339-345 (2018)
Purpose: Dose-volume histogram (DVH) toxicity relationships are poorly defined in men who receive radiation after radical prostatectomy (RP). We evaluated Radiation Therapy Oncology Group (RTOG) study 0534 and institutional intact normal-tissue spari
Externí odkaz: https://doaj.org/article/a0ea01bdb4b74059b69aa3460e0a388b
Zobrazit plný text záznamu
7
Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer
Autor: Nancy Y. Greenland, Matthew R. Cooperberg, Anthony C. Wong, Emily Chan, Peter R. Carroll, Jeffry P. Simko, Bradley A. Stohr
Publikováno v: Investigative and Clinical Urology
Investigative and Clinical Urology, Vol 63, Iss 1, Pp 27-33 (2022)
Investigative and clinical urology, vol 63, iss 1
Purpose Among Gleason pattern 4 types, cribriform pattern is associated with the worst outcomes. We hypothesized that larger cribriform patterns would be associated with increased Decipher scores and higher biochemical recurrence (BCR) risk in Gleaso
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e0de08e79289813db6e7dd47d1ed2f
http://europepmc.org/articles/PMC8756156
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje